KemPharm (KMPH) Financials

$4.97

$0.03 (0.61%)

As on 03-May-2023 09:30EDT

Market cap

$200 Mln

Revenue (TTM)

$9 Mln

P/E Ratio

--

P/B Ratio

1.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	9.37	10.46	28.65	13.29	12.84	--
Cost of Revenue	0.46	0.34	2.06	1.31	2.95	--
Gross Profit	8.91	10.12	26.59	11.98	9.89	--
Operating Expenses	27.16	34.96	18.86	16.76	30.23	54.27
Operating Profit (EBIT)	-16.61	-24.84	7.73	-4.78	-20.34	-55.90
Other Income	1.75	0.51	--	-2.40	0.65	4.78
Profit before Tax	-52.33	-42.33	-8.52	-12.79	-24.54	-56.59
Provision for Tax	-12.65	-0.79	0.03	-0.03	-0.02	-0.13
Profit after Tax (Net Income)	-39.68	-41.54	-8.56	-12.76	-24.52	-56.47
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-51.45	-41.54	-62.90	-12.76	-24.52	-56.47

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	71.40	85.81	127.12	-66.41	-74.46	-66.57
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	19.58	18.00	1.59	70.09	79.53	81.31
Current Liabilities	15.62	11.73	4.23	7.54	5.43	12.00
Total Liabilities	122.21	115.53	132.94	11.21	10.51	26.75

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	2.32	22.51	17.89	2.83	3.87	3.03
Current Assets	104.28	93.02	115.06	8.38	6.63	23.72
Total Assets	210.88	115.53	132.94	11.21	10.51	26.75
Total Debt*	14.12	14.12	1.59	70.35	79.53	81.65
Net Current Assets	--	81.30	110.83	0.85	1.20	11.72

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-18.72	10.44	-1.94	-23.74	-54.20
Cash Flow from Investing Activities	--	-36.72	-15.52	-0.03	3.23	33.33
Cash from Financing Activities	--	8.35	113.11	2.74	4.94	28.02
Net Cash Inflow / Outflow	--	-47.08	--	0.77	-15.56	7.15

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-36.34	-12.90	-283.15	-243.30	-221.21
ROE (%)	-68.80	-39.02	-28.19	18.12	34.78	91.01
ROA (%)	-23.37	-33.44	-11.87	-117.52	-131.65	-142.59
EBIT Margin (%)	-177.25	-237.54	26.98	-35.98	-158.40	--
Net Margin (%)	-356.73	-378.73	-29.86	-117.19	-181.78	-1,181.30
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	-54.28	-0.63	1.16	0.03	--	--
EBIT Growth (%)	-8,164.68	-421.41	261.66	76.49	58.92	-37.16
Net Profit Growth (%)	-103,231.31	-385.60	32.95	47.97	56.57	-30.15
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	--	--	--	--	--
Price / Book Value	1.69	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.78	2.85	-13.88	-14.10	-3.81	-1.22
Close Price ($)	5.50	4.59	8.71	11.20	6.07	28.48
High Price ($)	6.92	9.43	18.15	22.08	45.60	134.40
Low Price ($)	4.00	4.00	5.08	1.94	4.24	27.43
Market Cap ($ Cr)	200.47	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	0.16	0.01	-1.06	-1.07	-1.23
Short term debt to equity ratio	0.01	0.01	0.00	-0.01	0.00	-0.05
Current Ratio	6.68	7.93	27.20	1.11	1.22	1.98
Quick Ratio	6.64	7.88	--	--	--	--
Interest Coverage	-144.36	-74.16	20.56	-0.67	-3.12	-6.99

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	83.46	79.36	5.33	19.41	14.53	--
Asset Turnover	0.06	0.08	0.40	1.22	0.69	--
Receivable days	--	171.61	26.18	61.08	28.52	--
Inventory Days	--	714.53	--	--	--	--
Payable days	--	2,197.36	149.90	323.83	301.07	--
Cash Conversion Cycle	--	-1,311.22	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.